Cargando…

Exploiting DNA repair defects in colorectal cancer

Colorectal cancer (CRC) is the third leading cause of cancer‐related deaths worldwide. Therapies that take advantage of defects in DNA repair pathways have been explored in the context of breast, ovarian, and other tumor types, but not yet systematically in CRC. At present, only immune checkpoint bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reilly, Nicole M., Novara, Luca, Di Nicolantonio, Federica, Bardelli, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441925/ https://www.ncbi.nlm.nih.gov/pubmed/30714316 http://dx.doi.org/10.1002/1878-0261.12467

Ejemplares similares

Evolving neoantigen profiles in colorectal cancers with DNA repair defects
por: Rospo, Giuseppe, et al.
Publicado: (2019)

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2009)

Exploiting DNA repair defects for novel cancer therapies
por: van Gent, Dik C., et al.
Publicado: (2016)

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
por: Patelli, Giorgio, et al.
Publicado: (2023)

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
por: Amodio, Vito, et al.
Publicado: (2021)

Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
por: Durinikova, Erika, et al.
Publicado: (2022)

Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair
por: Thompson, Marlo K., et al.
Publicado: (2021)

Exploiting DNA repair defects in triple negative breast cancer to improve cell killing
por: Lee, Kevin J., et al.
Publicado: (2020)

Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients
por: Crisafulli, Giovanni, et al.
Publicado: (2019)

Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches
por: Farolfi, Alberto, et al.
Publicado: (2019)

DDX11 loss causes replication stress and pharmacologically exploitable DNA repair defects
por: Jegadesan, Nanda Kumar, et al.
Publicado: (2021)

Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients
por: Crisafulli, Giovanni, et al.
Publicado: (2022)

Inactivation of DNA repair—prospects for boosting cancer immune surveillance
por: Truini, Anna, et al.
Publicado: (2018)

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions
por: Picco, Gabriele, et al.
Publicado: (2017)

Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
por: Amodio, Vito, et al.
Publicado: (2023)

DNA repair defects in cancer and therapeutic opportunities
por: Hopkins, Jessica L., et al.
Publicado: (2022)

A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells
por: Russo, Mariangela, et al.
Publicado: (2022)

Infections in DNA Repair Defects
por: Yilmaz Demirdag, Yesim, et al.
Publicado: (2023)

Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer
por: Lorenzato, Annalisa, et al.
Publicado: (2020)

Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies
por: Russo, Mariangela, et al.
Publicado: (2018)

The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
por: Pergolizzi, Margherita, et al.
Publicado: (2022)

Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
por: Misale, Sandra, et al.
Publicado: (2015)

Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
por: Sartore-Bianchi, Andrea, et al.
Publicado: (2009)

The role of PARP in DNA repair and its therapeutic exploitation
por: Javle, M, et al.
Publicado: (2011)

Neural Tube Defects and Folate Deficiency: Is DNA Repair Defective?
por: Wang, Xiuwei, et al.
Publicado: (2023)

Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target
por: Raimundo, Liliana, et al.
Publicado: (2021)

Defective DNA repair mechanisms in prostate cancer: impact of olaparib
por: De Felice, Francesca, et al.
Publicado: (2017)

Human Papillomavirus and the DNA Damage Response: Exploiting Host Repair Pathways for Viral Replication
por: Spriggs, Chelsey C., et al.
Publicado: (2017)

Exploiting the Nucleotide Substrate Specificity of Repair DNA Polymerases To Develop Novel Anticancer Agents
por: Crespan, Emmanuele, et al.
Publicado: (2011)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
por: Van Emburgh, Beth O., et al.
Publicado: (2016)

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
por: Amatu, Alessio, et al.
Publicado: (2019)

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy
por: Nickoloff, Jac A., et al.
Publicado: (2021)

Role of DNA repair defects in predicting immunotherapy response
por: Zhang, Jing, et al.
Publicado: (2020)

BRCA1 and Metastasis: Outcome of Defective DNA Repair
por: Krishnan, Rehna, et al.
Publicado: (2021)

RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer
por: Khawaja, Hajrah, et al.
Publicado: (2020)

Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1
por: Rajarajan, Savitha, et al.
Publicado: (2020)

Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
por: Rajendran, Praveen, et al.
Publicado: (2011)

Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects
por: Varga, Dominic, et al.
Publicado: (2013)

Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer
por: Mcilhatton, Michael A., et al.
Publicado: (2016)

Early‐onset colorectal cancer in young individuals
por: Mauri, Gianluca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ta29olthsplb9a1v4k6di63i1c